CO130 Subgroup Analysis of Quality-of-Life Outcomes in Patients Achieving F-VASI75: Pooled Results from Two Randomized Phase 3 Studies of Ruxolitinib Cream for the Treatment of Vitiligo
Abstract
Authors
AG Pandya N van Geel K Butler K Bibeau J Gao K Ezzedine